Medline, Inc. D&A increased by 2.8% to $254.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 2.8%, from $247.00M to $254.00M.
Higher levels typically reflect significant historical capital expenditures or acquisitions that are now being expensed over time.
This metric represents the non-cash accounting charges used to allocate the cost of tangible assets and intangible asset...
Capital-intensive hardware manufacturers generally show higher D&A relative to revenue than pure-play software companies.
depreciation_and_amortization_cf| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Value | $237.75M | $237.75M | $237.75M | $237.75M | $244.25M | $244.25M | $244.25M | $244.25M | $247.00M | $254.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +2.7% | +0.0% | +0.0% | +0.0% | +1.1% | +2.8% |
| YoY Change | — | — | — | — | +2.7% | +2.7% | +2.7% | +2.7% | +1.1% | +2.8% |